108 related articles for article (PubMed ID: 19102718)
1. Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.
Parmeggiani F; Gemmati D; Costagliola C; Sebastiani A; Incorvaia C
Pharmacogenomics; 2009 Jan; 10(1):81-95. PubMed ID: 19102718
[TBL] [Abstract][Full Text] [Related]
2. Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration.
Parmeggiani F; Costagliola C; Gemmati D; D'Angelo S; Perri P; Scapoli GL; Catozzi L; Federici F; Sebastiani A; Incorvaia C
Pharmacogenet Genomics; 2007 Dec; 17(12):1039-46. PubMed ID: 18004208
[TBL] [Abstract][Full Text] [Related]
3. Predictive role of gene polymorphisms affecting thrombin-generation pathway in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.
Parmeggiani F; Gemmati D; Costagliola C; Sebastiani A; Incorvaia C
Recent Pat DNA Gene Seq; 2009; 3(2):114-22. PubMed ID: 19519581
[TBL] [Abstract][Full Text] [Related]
4. Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia.
Parmeggiani F; Gemmati D; Costagliola C; Semeraro F; D'Angelo S; Perri P; Sebastiani A; Incorvaia C
Ophthalmology; 2010 Mar; 117(3):517-23. PubMed ID: 20044141
[TBL] [Abstract][Full Text] [Related]
5. Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.
Parmeggiani F; Costagliola C; Semeraro F; Romano MR; Rinaldi M; Gallenga CE; Serino ML; Incorvaia C; D'Angelo S; De Nadai K; Dell'Omo R; Russo A; Gemmati D; Perri P
Int J Mol Sci; 2015 Aug; 16(8):19796-811. PubMed ID: 26307969
[TBL] [Abstract][Full Text] [Related]
6. Genetic predictors of response to photodynamictherapy.
Parmeggiani F; Gemmati D; Costagliola C; Semeraro F; Perri P; D'Angelo S; Romano MR; De Nadai K; Sebastiani A; Incorvaia C
Mol Diagn Ther; 2011 Aug; 15(4):195-210. PubMed ID: 21913742
[TBL] [Abstract][Full Text] [Related]
7. Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration.
Parmeggiani F; Costagliola C; Gemmati D; D'Angelo S; Perri P; Campa C; Catozzi L; Federici F; Sebastiani A; Incorvaia C
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3100-6. PubMed ID: 18378576
[TBL] [Abstract][Full Text] [Related]
8. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration.
Parmeggiani F; Gallenga CE; Costagliola C; Semeraro F; Romano MR; Dell'Omo R; Russo A; De Nadai K; Gemmati D; D'Angelo S; Bolletta E; Sorrentino FS
Sci Rep; 2019 Feb; 9(1):2614. PubMed ID: 30796269
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic aspects in therapeutic management of subfoveal choroidal neovascularisation: role of factor XIII-A 185 T-allele.
Parmeggiani F; Costagliola C; Incorvaia C; Sebastiani A; Gemmati D
Curr Drug Targets; 2011 Feb; 12(2):138-48. PubMed ID: 20887247
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties.
Cruess AF; Zlateva G; Pleil AM; Wirostko B
Acta Ophthalmol; 2009 Mar; 87(2):118-32. PubMed ID: 18577193
[TBL] [Abstract][Full Text] [Related]
12. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
[TBL] [Abstract][Full Text] [Related]
13. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
Hamon F; Goeminne P
Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for age-related macular degeneration.
Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
[TBL] [Abstract][Full Text] [Related]
16. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.
Feng X; Xiao J; Longville B; Tan AX; Wu XN; Cooper MN; McAllister IL; Isaacs T; Palmer LJ; Constable IJ
Ophthalmology; 2009 Oct; 116(10):1908-12.e1. PubMed ID: 19692124
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
[TBL] [Abstract][Full Text] [Related]
18. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD].
Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H; ; ;
Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454
[TBL] [Abstract][Full Text] [Related]
19. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
Wykrota H; Gierek-Łapińska A
Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: from clinical trials to clinical practice.
Sickenberg M
Semin Ophthalmol; 2001 Dec; 16(4):207-12. PubMed ID: 15513442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
